Miss Tina Marie Luichinger, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 655 7th St, Robins Afb, GA 31098 Phone: 478-327-8352 |
Dr. Libertad Melendez, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 655 7th St, 78 Mdg/sgpfe, Robins Afb, GA 31098 Phone: 478-284-9484 |
Brandon Michael Reed, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 655 7th St Bldg 700a, 78 Mdg/sgpe, Robins Afb, GA 31098 Phone: 478-327-8352 |
John A Kauderman Jr., OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 655 South 7th St Bldg 700/700a, Robins Afb, GA 31098 Phone: 478-327-8352 |
Dr. Charles J Malone, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 655 7th St Bldg 700, Robins Afb, GA 31098 Phone: 478-327-8353 |
News Archive
With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is pleased to announce its new training simulator for pelvic floor repair, to be exhibited for the first time at the ACOG 59th Annual Clinical Meeting in Washington, DC, April 30- May 4, 2011.
U.S. Senator John McCain, 80, is on the way to recovery after undergoing a craniotomy operation to remove a blood clot from his brain. According to a statement released by the Mayo Clinic where he is being treated, Senator McCain underwent a routine physical examination followed by which the blood clot was detected in his brain. The surgery to remove the blood clot from above his left eye was performed at the Mayo Clinic Hospital in Phoenix on Friday 14th of July.
TWi Pharmaceuticals, Inc. today announced that it has entered into a Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc. (individually and collectively, "Takeda") to settle and dismiss all outstanding patent litigation related to TWi's generic dexlansoprazole delayed release capsules for oral administration in 30 mg and 60 mg dosage strengths.
› Verified 3 days ago